Please login to the form below

Not currently logged in
Email:
Password:

Health Canada

This page shows the latest Health Canada news and features for those working in and with pharma, biotech and healthcare.

The Final Frontier

The Final Frontier

Using Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) database, there are about 350, 000 medical cannabis patients in Canada or 1% of the population (see Figure 1). ... Rohit Khanna is the Managing Director of Catalytic

Latest news

  • Vertex calls NHS England ‘outrageous’ as Orkambi talks stall again Vertex calls NHS England ‘outrageous’ as Orkambi talks stall again

    Orkambi (ivacaftor/lumacaftor)  targets a mutation that around 50% of people with CF in the UK have, and has been shown to improve lung health and reduce hospitalisations. ... NHS England adds that it is not alone in being unable to make the drugs

  • EMA starts rapid review of Shire’s HAE antibody EMA starts rapid review of Shire’s HAE antibody

    Lanadelumab (SHP643) is also being assessed by Health Canada under a priority review application, and was submitted to the FDA last month.

  • Not in my backyard Not in my backyard

    And then after two years of doing this from Canada, the Secretary of Health and Human Services would have the authority to permit importation from countries in the Organisation for Economic ... And if 40% of US prescriptions flow through Canada, the

  • Sanofi/Regeneron bag first approval for Actemra rival sarilumab Sanofi/Regeneron bag first approval for Actemra rival sarilumab

    Competition to Roche’s blockbuster RA therapy heats up as Canada is first to licence new drug. ... Health Canada has given a green light to the interleukin-6 inhibitor - under the Kevzara brand name - for the treatment of moderately to severely active

  • Merck buys rights to NewLink’s Ebola vaccine Merck buys rights to NewLink’s Ebola vaccine

    Merck will gain exclusive rights to rVSV-EBOV, a vaccine candidate originally developed by the Public Health Agency of Canada (PHAC) that is currently in phase I clinical trials to prevent ... Additional phase I studies are planned to take place in

More from news
Approximately 2 fully matching, plus 36 partially matching documents found.

Latest Intelligence

  • Gathering pace: adaptive pathways Gathering pace: adaptive pathways

    Canada has also been developing the concept under the banner of 'progressive licensing'. ... and Finn Børlum-Kristensen from the European network for health technology assessment and Danish Health and Medicines Authority.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics